Episode notes
In this episode David Pinato comments on the ILCA 2022 session on Diagnosis, Imaging and Biomarkers for HCC. Hear his considerations and analysis on novel biomarkers, protein biomarkers and gut microbiomes as potential sources of clinical available biomarkers in the setting of early diagnosis of liver cancers.